Kwick Forensic Solutions Ltd

Kwick Forensic Solutions Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda item for this meeting is the consideration and approval of the company's unaudited financial results for the quarter and half-year ended September 30, 2026. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Kwick Forensic Solutions Limited has announced the receipt of two orders from the Forensic Science Department, Chennai, totaling INR 2.53 crores (including GST). These orders are for the supply of Genetic Analyzers with accessories and kits. One order is valued at INR 1.12 crores for a 3500 Genetic Analyser with 8 Capillary accessories and kits, and the second order is for INR 1.41 crores for a 3500 Genetic Analyser with 24 Capillary accessories and kits. Both orders are to be executed within 3 months from the purchase order date, with a completion deadline of February 4, 2027. The orders are from a domestic entity and do not involve any interest from promoters or promoter group companies.

Kwick Forensic Solutions Limited has responded to a stock exchange query regarding the significant movement in its share price. The company stated that it is unaware of any undisclosed price-sensitive information or material events that could explain the price fluctuation. Kwick Forensic Solutions confirmed its compliance with SEBI listing regulations and indicated that the price movement appears to be driven by market forces. The company is not aware of any specific reason attributable to it for this movement.

Kwick Forensic Solutions Limited has announced the closure of its trading window for dealing in the company's securities. This closure is effective from October 01, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. The decision aligns with SEBI regulations, stock exchange circulars, and the company's internal code of conduct regarding insider trading. The specific date for the board meeting to consider these financial results will be communicated later.

Kwick Forensic Solutions (BSE - SME: 544895) has issued a press release highlighting its alignment with emerging opportunities in India's forensic infrastructure development. The government's investment of ₹150 crore in the National Forensic Sciences University (NFSU) Varanasi campus, set to be an advanced centre for forensic science, presents potential avenues for Kwick. The company, offering integrated solutions in forensic science, digital investigation, and evidence management, is well-positioned to support institutions and law-enforcement agencies as India enhances its scientific and technology-led investigation capabilities. Kwick's diversified portfolio includes forensic science, cyber forensics, DNA forensics, mobile CSI vehicles, and forensic equipment, aligning with the expansion of forensic infrastructure across various government bodies.

Kwick Forensic Solutions Ltd is positioning itself to capitalize on emerging opportunities within the forensic and law-enforcement sector. This strategic outlook is driven by the government's focus on strengthening India's forensic infrastructure, exemplified by the development of a ₹150 crore permanent campus for the National Forensic Sciences University (NFSU) in Varanasi. The company believes its integrated portfolio of forensic and law-enforcement solutions makes it well-suited to participate in this growth area.

Kwick Forensic Solutions Limited has responded to stock exchange queries regarding significant price movements in its securities. The company stated it is unaware of any information, event, development, or impending announcement that could explain the price fluctuation. Kwick Forensic Solutions confirmed that there is no undisclosed price-sensitive information or material event requiring disclosure under SEBI regulations. The company asserts it has complied with all disclosure obligations and attributes the price movement to market-driven factors, stating no specific company-related reason is known.